Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Gut and Liver|April 5, 2011
Infliximab therapy impacts the peripheral immune system of immunomodulator and corticosteroid naïve patients with Crohn's diseaseKyoichi Kato, Ken Fukunaga, Koji Kamikozuru, et al.International Journal of Clinical Oncology|September 18, 2004
Mechanism of carcinogenesis in familial tumorsKazuo Tamura, Joji Utsunomiya, Takeo Iwama, et al.Journal of Clinical Apheresis|November 16, 2011
Optimal apheresis treatment volume for the efficacy and safety of leukocytapheresis with Cellsorba in patients with active ulcerative colitisKen Fukunaga, Koji Kamikozuru, Yoko Yokoyama, et al.Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|September 3, 2011
Immunoregulatory effects of adsorptive granulocyte and monocyte apheresis in patients with drug refractory Crohn's diseaseKazuko Nagase, Ken Fukunaga, Shinichiro Kashiwamura, et al.Inflammatory Bowel Diseases|November 15, 2011
Scheduled infliximab monotherapy to prevent recurrence of Crohn's disease following ileocolic or ileal resection: a 3-year prospective randomized open trialKoji Yoshida, Ken Fukunaga, Hiroki Ikeuchi, et al.Journal of Gastroenterology|February 8, 2003
IL18 polymorphism is associated with an increased risk of Crohn's diseaseKazuo Tamura, Yoshihiro Fukuda, Hiroko Sashio, et al.Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|September 3, 2011
Relevance of the processed blood volume per granulocyte and monocyte apheresis session to its clinical efficacy in patients with ulcerative colitisRisa Kikuyama, Ken Fukunaga, Mikio Kawai, et al.Pageof 1